EntryPoint Capital LLC Invests $763,000 in The Cooper Companies, Inc. $COO

Key Points

• EntryPoint Capital LLC has invested $763,000 in The Cooper Companies, purchasing 9,050 shares, making it the firm's 18th largest holding.
• The Cooper Companies reported an EPS of $0.96 for the recent quarter, exceeding analysts' expectations and showing a 6.3% year-over-year revenue increase.
• Several institutional investors have increased their stakes in Cooper Companies, with 24.39% of the stock now owned by institutional investors and hedge funds.

EntryPoint Capital LLC purchased a new position in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 9,050 shares of the medical device company's stock, valued at approximately $763,000. Cooper Companies makes up approximately 0.3% of EntryPoint Capital LLC's holdings, making the stock its 18th largest holding.

Other institutional investors have also recently bought and sold shares of the company. Mirae Asset Global Investments Co. Ltd. boosted its stake in Cooper Companies by 15.1% during the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 26,189 shares of the medical device company's stock worth $2,194,000 after buying an additional 3,440 shares in the last quarter. DAVENPORT & Co LLC boosted its stake in Cooper Companies by 13.4% during the first quarter. DAVENPORT & Co LLC now owns 4,335 shares of the medical device company's stock worth $366,000 after buying an additional 513 shares in the last quarter. Cerity Partners LLC boosted its stake in Cooper Companies by 6.6% during the first quarter. Cerity Partners LLC now owns 17,113 shares of the medical device company's stock worth $1,443,000 after buying an additional 1,054 shares in the last quarter. State of Alaska Department of Revenue boosted its stake in Cooper Companies by 3.0% during the first quarter. State of Alaska Department of Revenue now owns 23,390 shares of the medical device company's stock worth $1,972,000 after buying an additional 680 shares in the last quarter. Finally, Cetera Investment Advisers boosted its stake in Cooper Companies by 1.3% during the fourth quarter. Cetera Investment Advisers now owns 24,049 shares of the medical device company's stock worth $2,211,000 after buying an additional 312 shares in the last quarter. Institutional investors and hedge funds own 24.39% of the company's stock.

Cooper Companies Price Performance

Shares of COO stock opened at $74.02 on Wednesday. The stock has a 50-day moving average price of $71.98 and a 200 day moving average price of $78.65. The company has a quick ratio of 1.23, a current ratio of 2.10 and a debt-to-equity ratio of 0.30. The firm has a market cap of $14.80 billion, a price-to-earnings ratio of 35.93, a PEG ratio of 1.79 and a beta of 1.00. The Cooper Companies, Inc. has a 12 month low of $65.00 and a 12 month high of $112.38.

Cooper Companies (NASDAQ:COO - Get Free Report) last announced its quarterly earnings data on Thursday, May 29th. The medical device company reported $0.96 EPS for the quarter, topping analysts' consensus estimates of $0.93 by $0.03. The firm had revenue of $1 billion during the quarter, compared to analyst estimates of $995.12 million. Cooper Companies had a return on equity of 9.60% and a net margin of 10.39%.The company's revenue was up 6.3% on a year-over-year basis. During the same period last year, the company earned $0.85 earnings per share. Cooper Companies has set its FY 2025 guidance at 4.050-4.110 EPS. Research analysts expect that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on COO shares. BNP Paribas Exane upgraded shares of Cooper Companies from a "neutral" rating to an "outperform" rating and set a $92.00 price target on the stock in a research note on Tuesday, July 22nd. BNP Paribas raised Cooper Companies from a "hold" rating to a "strong-buy" rating in a report on Tuesday, July 22nd. Robert W. Baird cut their price objective on Cooper Companies from $107.00 to $97.00 and set an "outperform" rating for the company in a report on Friday, May 30th. Mizuho cut their price objective on Cooper Companies from $105.00 to $90.00 and set an "outperform" rating for the company in a report on Wednesday, July 16th. Finally, Wells Fargo & Company cut their price objective on Cooper Companies from $118.00 to $93.00 and set an "overweight" rating for the company in a report on Friday, May 30th. One equities research analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat, Cooper Companies currently has an average rating of "Moderate Buy" and an average target price of $96.73.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.